The transcription factor PU.1 is involved in macrophage proliferation

被引:127
|
作者
Celada, A
Borras, FE
Soler, C
Lloberas, J
Klemsz, M
vanBeveren, C
McKercher, S
Maki, RA
机构
[1] UNIV BARCELONA, FDN AUGUST PI & SUNYER, E-08028 BARCELONA, SPAIN
[2] INDIANA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, INDIANAPOLIS, IN 46202 USA
[3] SIDNEY KIMMEL CANC CTR, SAN DIEGO, CA 92121 USA
[4] LA JOLLA CANC RES FDN, LA JOLLA, CA 92037 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 184卷 / 01期
关键词
D O I
10.1084/jem.184.1.61
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PU.1 is a tissue-specific transcription factor that is expressed in cells of the hematopoietic lineage including macrophages, granulocytes, and B lymphocytes. Bone marrow-derived macrophages transfected with an antisense PU.1 expression construct or treated with antisense oligonucleotides showed a decrease in proliferation compared with controls. In contrast, bone marrow macrophages transfected with a sense PU.1 expression construct displayed enhanced macrophage colony-stimulating factor (M-CSF)-dependent proliferation. Interestingly, there was no effect of sense or antisense constructs of PU.1 on the proliferation of the M-C:SF-independent cell line, suggesting that the response was M-CSF dependent. This was further supported by the finding that macrophages transfected with :I sense or an antisense PU.1 construct showed, respectively, an increased or a reduced level of surface expression of receptors for M-CSF. The enhancement of proliferation seems to be selective for PU.1, since transfections with several other members of the ets family, including ets -2 and fli-1, had no effect. Various mutants of PU.1 were also tested for their ability to affect macrophage proliferation. A reduction in macrophage proliferation was found when cells were transfected with a construct in which the DNA-binding domain of PU.1 was expressed. The PEST (proline-, glutamic acid-, serine-, and threonine-rich region) sequence of the PU.1 protein, which is an important domain for protein-protein interactions in B cells, was found to have no influence on PU.1-enhanced macrophage proliferation when an expression construct containing PU.1 minus the PEST domain was transfected into bone marrow-derived macrophages. In vivo, PU.1 is phosphorylated on several serine residues. The transfection of plasmids containing PU.1 with mutations at each of five serines showed that only positions 41 and 45 are critical for enhanced macrophage proliferation. We conclude that PU.1 is necessary for the M-CSF-dependent proliferation of macrophages. One of the proliferation-relevant targets of this transcription factor could be the M-CSF receptor.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 50 条
  • [1] Transcription factor PU.1 is involved in the progression of glioma
    Xu, Yuanzhi
    Gu, Song
    Bi, Yunke
    Qi, Xiangqian
    Yan, Yujin
    Lou, Meiqing
    ONCOLOGY LETTERS, 2018, 15 (03) : 3753 - 3759
  • [2] The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation
    Qian, Feng
    Deng, Jing
    Lee, Yong Gyu
    Zhu, Jimmy
    Karpurapu, Manjula
    Chung, Sangwoon
    Zheng, Jun-Nian
    Xiao, Lei
    Park, Gye Young
    Christman, John W.
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2015, 7 (06) : 557 - 567
  • [3] Transcription factor PU.1 and dendritic cell development
    不详
    IMMUNOTHERAPY, 2010, 2 (06) : 754 - 754
  • [4] The role of the transcription factor PU.1 in lung cancer
    Hohenberger, Katja
    Trufa, Denis
    Gebbert, Carol
    Rieker, Ralf
    Sirbu, Horia
    Finotto, Susetta
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [5] DNA selection by the master transcription factor PU.1
    Terrell, J. Ross
    Taylor, Samuel J.
    Schneider, Amelia L.
    Lu, Yue
    Vernon, Tyler N.
    Xhani, Suela
    Gumpper, Ryan H.
    Luo, Ming
    Wilson, W. David
    Steidl, Ulrich
    Poon, Gregory M. K.
    CELL REPORTS, 2023, 42 (07):
  • [6] Pharmacological inhibition of the transcription factor PU.1 in leukemia
    Antony-Debre, Ileana
    Paul, Ananya
    Leite, Joana
    Mitchell, Kelly
    Kim, Hye Mi
    Carvajal, Luis A.
    Todorova, Tihomira I.
    Huang, Kenneth
    Kumar, Arvind
    Farahat, Abdelbasset A.
    Bartholdy, Boris
    Narayanagari, Swathi-Rao
    Chen, Jiahao
    Ambesi-Impiombato, Alberto
    Ferrando, Adolfo A.
    Mantzaris, Ioannis
    Gavathiotis, Evripidis
    Verma, Amit
    Will, Britta
    Boykin, David W.
    Wilson, W. David
    Poon, Gregory M. K.
    Steidl, Ulrich
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12): : 4297 - 4313
  • [7] The role of the PU.1 transcription factor in osteoclastogenesis.
    Barnes, GL
    Marecki, S
    Einhorn, TA
    Fenton, MJ
    Gerstenfeld, LC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S505 - S505
  • [8] Mechanisms of Cistromic Repositioning of the Transcription Factor PU.1
    Taylor, Samuel
    Stauber, Jacob
    Bohorquez, Oliver
    Bartholdy, Boris
    Schwenger, Emily
    Farahat, Abdelbasset A.
    Wheat, Justin
    Boykin, David W.
    Poon, Gregory M. K.
    Steidl, Ulrich G.
    BLOOD, 2022, 140 : 3011 - 3011
  • [9] PU.1 transcription factor, hematopoiesis, and bone formation
    Labie, D
    M S-MEDECINE SCIENCES, 1997, 13 (05): : 724 - 725
  • [10] THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE
    KLEMSZ, MJ
    MCKERCHER, SR
    CELADA, A
    VANBEVEREN, C
    MAKI, RA
    CELL, 1990, 61 (01) : 113 - 124